From: Prognostic value of cardiopulmonary exercise testing in patients with systemic sclerosis
Mortality | Hazard ratio | p-value | 95% Confidence interval | Harrell’s C | N |
---|---|---|---|---|---|
Model 1 | 0.96 | 148 | |||
 Age | 1.163 | 0.000 | 1070; 1264 |  |  |
 KCO | 0.947 | 0.003 | 0.915; 0.981 |  |  |
 PeakVO2 (ml/kg/min) | 0.653 | 0.000 | 0.529; 0.806 |  |  |
 FVC | 0.942 | 0.000 | 0.913; 0.973 |  |  |
Model 2 | 0.95 | 150 | |||
 Age | 1.272 | 0.000 | 1.143; 1.416 |  |  |
 VE/VCO2-slope | 0.900 | 0.018 | 0.825; 0.982 |  |  |
 KCO | 0.918 | 0.008 | 0.862; 0.978 |  |  |
 FVC | 0.909 | 0.000 | 0.863; 0.957 |  |  |
 PeakVO2 (% pred.) | 0.869 | 0.000 | 0.807; 0.937 |  |  |